Litcius/Paper detail

Continuous bioactivity-dependent evolution of an antibiotic biosynthetic pathway

Chad W. Johnston, Ahmed H. Badran, James J. Collins

2020Nature Communications31 citationsDOIOpen Access PDF

Abstract

Antibiotic biosynthetic gene clusters (BGCs) produce bioactive metabolites that impart a fitness advantage to their producer, providing a mechanism for natural selection. This selection drives antibiotic evolution and adapts BGCs for expression in different organisms, potentially providing clues to improve heterologous expression of antibiotics. Here, we use phage-assisted continuous evolution (PACE) to achieve bioactivity-dependent adaptation of the BGC for the antibiotic bicyclomycin (BCM), facilitating improved production in a heterologous host. This proof-of-principle study demonstrates that features of natural bioactivity-dependent evolution can be engineered to access unforeseen routes of improving metabolic pathways and product yields.

Topics & Concepts

HeterologousAntibioticsDirected Molecular EvolutionBiologyComputational biologyGeneNatural productAdaptation (eye)Selection (genetic algorithm)Heterologous expressionNatural selectionBacteriaDirected evolutionMicrobiologyGeneticsBiochemistryRecombinant DNAComputer scienceArtificial intelligenceNeuroscienceMutantMicrobial Natural Products and BiosynthesisCRISPR and Genetic EngineeringGenomics and Phylogenetic Studies
Continuous bioactivity-dependent evolution of an antibiotic biosynthetic pathway | Litcius